Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Sep;83(18):7059-63.
doi: 10.1073/pnas.83.18.7059.

Antitumor Effects of L6, an IgG2a Antibody That Reacts With Most Human Carcinomas

Free PMC article

Antitumor Effects of L6, an IgG2a Antibody That Reacts With Most Human Carcinomas

I Hellström et al. Proc Natl Acad Sci U S A. .
Free PMC article

Abstract

Mouse monoclonal antibody L6 (IgG2a subtype) recognizes a ganglioside antigen expressed at the surface of cells from human non-small-cell lung carcinomas, breast carcinomas, and colon carcinomas. We now show that this antibody can lyse L6 antigen-positive human tumor cells in the presence of Leu-11b-positive human lymphocytes (i.e., mediate antibody-dependent cellular cytotoxicity) or human serum (mediate complement-dependent cytotoxicity) and that it can inhibit the outgrowth of an L6 antigen-positive human tumor transplanted onto nude mice.

Similar articles

See all similar articles

Cited by 18 articles

See all "Cited by" articles

References

    1. J Immunol. 1983 Jul;131(1):180-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Jan;81(1):216-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1242-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1499-502 - PubMed
    1. J Nucl Med. 1986 Jun;27(6):824-8 - PubMed

Publication types

LinkOut - more resources

Feedback